Paul M. Barr, M.D.

Paul M. Barr, M.D.

Contact Information

James P. Wilmot Cancer Center
601 Elmwood Ave.
Rochester, NY 14642

Appointment: (585) 275-5823

  • Accepting New Patients Accepting New Patients
  • Admits to Strong Memorial Hospital Admits to Strong Memorial Hospital
  • Admits to Highland Hospital Admits to Highland Hospital

Professional Bio

Paul M. Barr, M.D. is an Associate Professor of Medicine and Director of the Clinical Trials Office for the Wilmot Cancer Institute.

Dr. Barr received his medical degree from Northeast Ohio Medical University. His postgraduate training included an internship, residency and chief residency at Case Western Reserve University. He subsequently completed a hematology and oncology fellowship at Case Western and now holds subspecialty certification in Internal Medicine, Hematology and Oncology.

He is a member of the lymphoma committee in the Southwest Oncology Group and serves as principal investigator on several local and national clinical trial treatment protocols for chronic lymphocytic leukemia and non-Hodgkin lymphoma.

His research interests focus on the development of novel therapeutics for patients with chronic lymphocytic leukemia and lymphoma. He has received a NIH funded K12 award during his training for his work with the organic amine Methoxyamine to improve the effect of fludarabine for CLL patients. Most recently, he was awarded a Clinical Research award from the Lymphoma Research Foundation based o his work developing combination therapies targeting molecules within the B cell receptor pathway for CLL and lymphoma patients.

Patient Care Bio

As the Director of the Clinical Trials Office for Wilmot Cancer Institute, I oversee our state-of-the-art clinical trials while also educating my patients about their disease so they are as informed as possible. This enables my patients to participate in the process of making the best treatment decisions.

Individual patients drew me into the field of hematology/oncology. I am driven by the desire to develop better, less toxic treatments for our lymphoma and leukemia patients. I also have an amazing team working with me that is focused on communicating with and educating our patients, helping them in every aspect of their lives.

If I were to recommend one thing to patients, it would be to ask about clinical trials. While a clinical trial may not be appropriate in every circumstance, all patients should learn about these important options.

Conditions I Treat

- Non-Hodgkin lymphoma
- Hodgkin lymphoma
- Chronic lymphocytic leukemia

Awards & Honors (National)

Lymphoma Research Foundation Clinical Investigator 2012 - 2015
NIH Loan Repayment Program Award Recipient | NIH 2011 - 2014
American Society of Hematology Clinical Research Training Institute 2009
NIH/NCI K12 Paul Calabresi Scholar | NIH | University Hospitals Case Medical Center, Case Western Resrve 2008

Awards & Honors (Local)

Wilmot Cancer Research Fellowship 2011 - 2014
John W. Harris, MD Hematology Scholar Award | Case Western Reserve University 2006 - 2007
Chief Medical Resident | Case Western Reserve University/University Hospitals 2003 - 2004

Current Appointments

Medical Director, Cancer Center Clinical Trials Office - Department of Medicine (SMD)
Associate Professor - Department of Medicine, Hematology/Oncology (SMD) - Primary
Associate Professor - Cancer Center


Internal Medicine - American Board of Internal Medicine
Hematology - American Board of Internal Medicine
Medical Oncology - American Board of Internal Medicine


MD | Medicine | Northeastern Ohio Univs Med Sch2000
BA | Zoology | Miami University-Oxford1996

Post-Doctoral Training & Residency

Fellowship in Hematology/Oncology at University Hospitals of Cleveland07/01/2004 - 06/30/2007
Residency in Internal Medicine at University Hospitals of Cleveland07/01/2001 - 06/30/2003
Internship in Internal Medicine at University Hospitals of Cleveland07/01/2000 - 06/30/2001